Clinical trial Recruiting at 1 site Observational Ages 18 and up

Investigating graft failure after heart bypass surgery

Official title: Vein Graft Failure and Cardiovascular Consequences of Coronary Artery Bypass Graft Surgery

Run by University of Edinburgh · NCT06800430 · Data updated 2026-11-12

This study looks at why heart bypass grafts fail by using special scans and tests on people who have had the surgery and those who might have problems with their grafts.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment70 (estimated)
SponsorUniversity of Edinburgh
Academic / other
Locations1 site (Edinburgh, Midlothian)
StatusRecruiting
StartedMarch 28, 2025
Main results expectedMarch 28, 2027
Study endsAugust 6, 2027
Registry record updatedApril 20, 2026
Trial IDNCT06800430 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 undergoing CABG surgery with at least one saphenous vein graft or those with suspected graft vasculopathy after previous CABG.

Probably not a fit

Patients with a life expectancy of less than two years, renal failure, or those on immunosuppressive therapies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study aims to understand the causes of graft failure following coronary artery bypass graft (CABG) surgery. It will utilize total-body Positron Emission Tomography (PET) scans to examine inflammation, thrombosis, and fibrosis in saphenous vein grafts. Participants will be divided into two cohorts: one undergoing CABG surgery and another with suspected vein graft failure. Clinical reviews, blood sampling, echocardiograms, and advanced imaging techniques will be employed to gather comprehensive data over time.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of graft failure, potentially enhancing patient outcomes after CABG surgery.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in understanding graft failure, but the specific use of total-body PET imaging in this context is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
INCLUSION CRITERIA:

Cohort 1: Patients undergoing CABG surgery

* Males and females over 18 years of age
* Patients undergoing CABG surgery for multivessel coronary artery disease, who receive at least one saphenous vein graft

Cohort 2: Patients with symptomatic saphenous vein graft vasculopathy

* Males and females over 18 years of age
* Patients who underwent CABG surgery ≥ 5 years prior to recruitment for multivessel disease and received 2 or more saphenous vein grafts
* Referred for invasive coronary angiography due to recurrent symptoms and with a high suspicion of graft vasculopathy

EXCLUSION CRITERIA:

* Patients with a life expectancy of \< 2 years
* Renal failure (estimated glomerular filtration rate \<30 mL/min/1.73 m2)
* Patients on immunosuppressive therapies
* Females of child-bearing age who are pregnant or breastfeeding,
* Known allergy or contraindications to iodinated contrast or radiotracer
* Patients who are unable to tolerate the supine position
* Patients who are unable to provide informed consent

Where it's running

  • Royal Infirmary of Edinburgh
    Edinburgh, Midlothian, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.